-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Attovia Therapeutics with Buy Rating, Announces Price Target of $30

Benzinga·08/31/2026 15:06:29
Listen to the news
Citigroup analyst Yigal Nochomovitz initiates coverage on Attovia Therapeutics (NASDAQ:ATTO) with a Buy rating and announces Price Target of $30.